Product Information
ANASTROZOLE 1 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1416 per EA under NDC 59651023690. Its NADAC has been published 295 times since Feb 10, 2021.
FDA first approved this application on Jul 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651023690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ANASTROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA212434FDA Approved
7/24/2020
TE Code
AB
On Market Since
7/24/2020
Pharmacological Classes
Price Statistics
The NADAC for ANASTROZOLE 1 MG TABLET has been published 295 times since Feb 10, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1416 per EA |
|---|---|
| All-time high | $0.1708 (Sep 11, 2024) |
| All-time low | $0.1041 (Jul 20, 2022) |
| 52-week high | $0.1461 |
| 52-week low | $0.1355 |
| Median price | $0.1382 |
| Average price | $0.1362 |
| Largest weekly change | +32.1% (Aug 21, 2024) |
| Weeks tracked | 295 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Anastrozole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aromatase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANASTROZOLE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ANASTROZOLE 1 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1416 per EA (NDC 59651023690), effective Sep 30, 2026.
How has the price of ANASTROZOLE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ANASTROZOLE 1 MG TABLET has held within roughly two percent of its current level. It has been tracked across 295 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for ANASTROZOLE 1 MG TABLET?
Since Feb 10, 2021, the NADAC for ANASTROZOLE 1 MG TABLET has ranged from a low of $0.1041 (Jul 20, 2022) to a high of $0.1708 (Sep 11, 2024), with a median of $0.1382 per EA.
Are there cheaper alternatives to ANASTROZOLE 1 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANASTROZOLE 1 MG TABLET, is $0.1366 per EA — about 4% below ANASTROZOLE 1 MG TABLET.
Who manufactures ANASTROZOLE 1 MG TABLET?
ANASTROZOLE 1 MG TABLET (NDC 59651023690) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.